Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Employee Benefits Expense by Year
Total Employee Benefits Expense ($M)
Novartis Total Employee Benefits Expense: $13,200M in FY2025, up 3.9% from a year earlier.
Latest, FY2025
13,200
Period ended Dec 31, 2025
Change on a year earlier
+3.9%
12,700 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 5.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Employee Benefits Expense ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13,200 | +3.9% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 12,700 | 0.0% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 12,700 | -3.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 13,100 | – | Novartis Form 20-F (0001370368-25-000004) ↗ |
Cite this data
StockData. (2026). Novartis Total Employee Benefits Expense ($M), annual FY2022–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/wf-emp-benefits-exp
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.